Novartis/Alcon Merger Clears FTC Hurdle With Minor Divestiture, But Shareholder Battle Continues

Novartis sells its miotic drug Miochol-E to Bausch & Lomb to avoid anticompetitive charges; a Novartis legal expert says a subset of Alcon's board cannot veto the transaction.